 <h1>Proloprim Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>trimethoprim</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about trimethoprim. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Proloprim.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to trimethoprim: oral solution, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, trimethoprim (the active ingredient contained in Proloprim) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking trimethoprim:</p><p>
<i>Less common</i>
</p><ul>
<li>Skin rash or itching</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Black, tarry stools</li>
<li>blood in urine or stools</li>
<li>bluish fingernails, lips, or skin</li>
<li>changes in facial skin color</li>
<li>chills </li>
<li>difficult breathing or shortness of breath</li>
<li>fever with or without chills</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>joint or muscle pain</li>
<li>nausea</li>
<li>neck stiffness</li>
<li>pale skin</li>
<li>pinpoint red spots on skin</li>
<li>redness, blistering, burning, tenderness, peeling, or loosening of skin or mucous membranes </li>
<li>redness, swelling, or soreness of tongue</li>
<li>red skin lesions, often with a purple center</li>
<li> sore throat</li>
<li>swelling</li>
<li> thickened or scaly skin</li>
<li>unusual bleeding or bruising </li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of trimethoprim may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>loss of appetite</li>
<li>nausea or vomiting</li>
<li>stomach cramps or pain</li>
</ul><p>
<!-- end oral solution, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to trimethoprim: compounding powder, oral solution, oral tablet</i></p><h3>General</h3><p>The most common side effects were pruritus, rash, and mild gastrointestinal disturbances (including nausea, vomiting, glossitis); these effects were generally mild and reversed quickly when the drug was stopped.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia</p>
<p><b>Very rare</b> (less than 0.01%): Hypoglycemia, hyponatremia, anorexia<sup>[Ref]</sup></p><p>Hyperkalemia has been reported, particularly in elderly patients and patients with HIV.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (e.g., maculopapular, morbilliform, pruritic), urticaria</p>
<p><b>Very rare</b> (less than 0.01%): Photosensitivity, angioedema, exfoliative dermatitis, fixed drug eruption, erythema multiforme, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's Syndrome), bullous dermatitis, purpura, allergic vasculitis (resembling Henoch-Schonlein purpura)</p>
<p><b>Frequency not reported</b>: Pruritus, phototoxic skin eruptions<sup>[Ref]</sup></p><p>Rash was generally mild to moderate and appeared 7 to 14 days after starting therapy.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting</p>
<p><b>Very rare</b> (less than 0.01%): Constipation, glossitis, stomatitis, pseudomembranous colitis, pancreatitis</p>
<p><b>Frequency not reported</b>: Epigastric distress, sore mouth, gastrointestinal disturbances, abdominal pain, Clostridioides difficile-associated diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Very rare</b> (less than 0.01%): Dyskinesias, aseptic meningitis, tremor, ataxia, dizziness, lethargy, syncope, paresthesia, convulsions, peripheral neuritis, vertigo, tinnitus<sup>[Ref]</sup></p><p>Aseptic meningitis reversed rapidly when this drug was stopped but recurred in a number of cases upon re-exposure to sulfamethoxazole-trimethoprim or this drug alone.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Monilial overgrowth</p>
<p><b>Very rare</b> (less than 0.01%): Drug fever</p>
<p><b>Frequency not reported</b>: Fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Fatalities have been reported (especially in elder patients or patients with renal or liver dysfunction), but most hematological changes were mild and reversed when therapy was stopped.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Thrombocytopenia, leukopenia, neutropenia, pancytopenia, bone marrow depression, agranulocytosis, aplastic anemia, hemolytic anemia, eosinophilia, purpura, hemolysis</p>
<p><b>Frequency not reported</b>: Megaloblastic anemia, methemoglobinemia, depression of hematopoiesis, hematological changes<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Fatalities have been reported with cholestatic jaundice and hepatic necrosis.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Disturbance in liver enzymes, elevated serum transaminases, elevated bilirubin, cholestatic jaundice, hepatic necrosis</p>
<p><b>Frequency not reported</b>: Elevated ALT, elevated AST<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity, anaphylaxis, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Depression, hallucinations, confusional states, agitation, anxiety, abnormal behavior, insomnia, nightmares<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Cough, shortness of breath, wheeze, epistaxis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very rare</b> (less than 0.01%): Myalgia, arthralgia, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Impaired renal function (including renal failure)</p>
<p><b>Frequency not reported</b>: Increased BUN, increased serum creatinine<sup>[Ref]</sup></p><p>Whether increased BUN and serum creatinine were due to inhibition of creatinine tubular secretion or genuine renal dysfunction was not established.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Hematuria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very rare</b> (less than 0.01%): Periarteritis nodosa<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Uveitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Trimethoprim (trimethoprim)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What antibiotics are used to treat UTI?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Proloprim (trimethoprim)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: urinary anti-infectives</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Trimpex, Primsol</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bladder Infection</li>
<li>Otitis Media</li>
<li>Pneumocystis Pneumonia</li>
<li>Prevention of Bladder infection</li>
<li>Urinary Tract Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to trimethoprim: compounding powder, oral solution, oral tablet</i></p><h3>General</h3><p>The most common side effects were pruritus, rash, and mild gastrointestinal disturbances (including nausea, vomiting, glossitis); these effects were generally mild and reversed quickly when the drug was stopped.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperkalemia</p><p><b>Very rare</b> (less than 0.01%): Hypoglycemia, hyponatremia, anorexia<sup>[Ref]</sup></p><p>Hyperkalemia has been reported, particularly in elderly patients and patients with HIV.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (e.g., maculopapular, morbilliform, pruritic), urticaria</p><p><b>Very rare</b> (less than 0.01%): Photosensitivity, angioedema, exfoliative dermatitis, fixed drug eruption, erythema multiforme, erythema nodosum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's Syndrome), bullous dermatitis, purpura, allergic vasculitis (resembling Henoch-Schonlein purpura)</p><p><b>Frequency not reported</b>: Pruritus, phototoxic skin eruptions<sup>[Ref]</sup></p><p>Rash was generally mild to moderate and appeared 7 to 14 days after starting therapy.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, diarrhea, vomiting</p><p><b>Very rare</b> (less than 0.01%): Constipation, glossitis, stomatitis, pseudomembranous colitis, pancreatitis</p><p><b>Frequency not reported</b>: Epigastric distress, sore mouth, gastrointestinal disturbances, abdominal pain, Clostridioides difficile-associated diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Very rare</b> (less than 0.01%): Dyskinesias, aseptic meningitis, tremor, ataxia, dizziness, lethargy, syncope, paresthesia, convulsions, peripheral neuritis, vertigo, tinnitus<sup>[Ref]</sup></p><p>Aseptic meningitis reversed rapidly when this drug was stopped but recurred in a number of cases upon re-exposure to sulfamethoxazole-trimethoprim or this drug alone.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Monilial overgrowth</p><p><b>Very rare</b> (less than 0.01%): Drug fever</p><p><b>Frequency not reported</b>: Fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Fatalities have been reported (especially in elder patients or patients with renal or liver dysfunction), but most hematological changes were mild and reversed when therapy was stopped.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Thrombocytopenia, leukopenia, neutropenia, pancytopenia, bone marrow depression, agranulocytosis, aplastic anemia, hemolytic anemia, eosinophilia, purpura, hemolysis</p><p><b>Frequency not reported</b>: Megaloblastic anemia, methemoglobinemia, depression of hematopoiesis, hematological changes<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Fatalities have been reported with cholestatic jaundice and hepatic necrosis.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Disturbance in liver enzymes, elevated serum transaminases, elevated bilirubin, cholestatic jaundice, hepatic necrosis</p><p><b>Frequency not reported</b>: Elevated ALT, elevated AST<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity, anaphylaxis, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very rare</b> (less than 0.01%): Depression, hallucinations, confusional states, agitation, anxiety, abnormal behavior, insomnia, nightmares<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Cough, shortness of breath, wheeze, epistaxis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very rare</b> (less than 0.01%): Myalgia, arthralgia, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Impaired renal function (including renal failure)</p><p><b>Frequency not reported</b>: Increased BUN, increased serum creatinine<sup>[Ref]</sup></p><p>Whether increased BUN and serum creatinine were due to inhibition of creatinine tubular secretion or genuine renal dysfunction was not established.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Hematuria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very rare</b> (less than 0.01%): Periarteritis nodosa<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very rare</b> (less than 0.01%): Uveitis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Trimethoprim (trimethoprim)." Teva Pharmaceuticals USA, North Wales, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What antibiotics are used to treat UTI?</li>
</ul><h2>More about Proloprim (trimethoprim)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: urinary anti-infectives</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bladder Infection</li>
<li>Otitis Media</li>
<li>Pneumocystis Pneumonia</li>
<li>Prevention of Bladder infection</li>
<li>Urinary Tract Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>